Stocks
Immunome (IMNM) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.00 | 0.55 | 4.87 | 1.40 | 3.08 | 2.48 | |||
| Changes by years, y/y, % | -13% | -72% | +783% | -71% | +119% | +6.0% | |||
Immunome. Debt/EBITDA
Immunome. Debt/EBITDA, changes, %
Immunome (IMNM) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.78 | 1.40 | 1.33 | 2.97 | 2.48 | 2.48 | ||
| Changes by years, y/y, % | -75% | -64% | -38% | +112% | +39% | |||
| Changes by quarters, q/q, % | +27% | -21% | -5% | +123% | -16% | |||
